THINK

Experience

1. TMC207-TiDP13-C209: Study Title A Phase II, open label trial to evaluate the safety, and tolerability and efficacy of TMC207 in subjects with sputum smear-positive pulmonary infection with multi-drug resistant Mycobacterium tuberculosis (MDR-TB)
2. TMC207-TiDP13-C208: Study Title A Phase II, placebo-controlled, double-blind, randomized trial to evaluate the anti-bacterial activity, safety, and tolerability of TMC207 in subjects with sputum smear-positive pulmonary infection with multi-drug resistant Mycobacterium tuberculosis (MDR-TB)
3. TB HAART Study: An evaluation of the impact of early initiation of HAART on TB treatment outcomes for TB patients co-infected with HIV.
4. The Evaluation of a Standardised Treatment Regimen of Anti Tuberculosis Drugs for patients with MDR-TB. Sub investigator. Protocol no: ISRCTN 78372190

Disease areas

• HIV
• Other
• TB